25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CHY (Chemometec) Stock Analysis
Buy, Hold or Sell?

Let's analyze Chemometec together

I guess you are interested in ChemoMetec A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Chemometec’s Financial Insights
  • 📈 Technical Analysis (TA) – Chemometec’s Price Targets

I'm going to help you getting a better view of ChemoMetec A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ChemoMetec A/S

I send you an email if I find something interesting about ChemoMetec A/S.

1. Quick Overview

1.1. Quick analysis of Chemometec (30 sec.)










1.2. What can you expect buying and holding a share of Chemometec? (30 sec.)

How much money do you get?

How much money do you get?
€2.48
When do you have the money?
1 year
How often do you get paid?
88.9%

What is your share worth?

Current worth
€5.18
Expected worth in 1 year
€8.50
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€5.46
Return On Investment
5.5%

For what price can you sell your share?

Current Price per Share
€100.20
Expected price per share
€82.06 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Chemometec (5 min.)




Live pricePrice per Share (EOD)
€100.20
Intrinsic Value Per Share
€8.24 - €14.18
Total Value Per Share
€13.42 - €19.36

2.2. Growth of Chemometec (5 min.)




Is Chemometec growing?

Current yearPrevious yearGrowGrow %
How rich?$104.5m$87.7m$16.7m16.0%

How much money is Chemometec making?

Current yearPrevious yearGrowGrow %
Making money$28.9m$21.1m$7.7m26.9%
Net Profit Margin37.6%33.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Chemometec (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Chemometec?

Welcome investor! Chemometec's management wants to use your money to grow the business. In return you get a share of Chemometec.

First you should know what it really means to hold a share of Chemometec. And how you can make/lose money.

Speculation

The Price per Share of Chemometec is €100.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chemometec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chemometec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €5.18. Based on the TTM, the Book Value Change Per Share is €0.83 per quarter. Based on the YOY, the Book Value Change Per Share is €0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.54 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chemometec.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.661.7%1.661.7%1.221.2%1.491.5%1.341.3%0.870.9%
Usd Book Value Change Per Share0.961.0%0.961.0%0.290.3%0.940.9%0.840.8%0.670.7%
Usd Dividend Per Share0.620.6%0.620.6%0.930.9%0.520.5%0.480.5%0.810.8%
Usd Total Gains Per Share1.591.6%1.591.6%1.221.2%1.461.5%1.321.3%1.471.5%
Usd Price Per Share91.63-91.63-47.17-70.52-91.82-59.22-
Price to Earnings Ratio55.09-55.09-38.79-46.51-77.62-60.83-
Price-to-Total Gains Ratio57.81-57.81-38.67-47.62-78.06-62.19-
Price to Book Ratio15.25-15.25-9.35-13.30-26.39-19.46-
Price-to-Total Gains Ratio57.81-57.81-38.67-47.62-78.06-62.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share116.29212
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.620.48
Usd Book Value Change Per Share0.960.84
Usd Total Gains Per Share1.591.32
Gains per Quarter (8 shares)12.6810.57
Gains per Year (8 shares)50.7242.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1203141152732
2406292315474
360931434681116
47912319462108158
59915424577134200
611918529692161242
7139216347108188284
8159247398123215326
9179278449139242368
10199309500154269410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%8.00.01.088.9%8.00.01.088.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ChemoMetec A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8310.8310%0.248+235%0.810+3%0.724+15%0.575+44%
Book Value Per Share--5.1775.1770%4.346+19%4.541+14%3.681+41%2.484+108%
Current Ratio--3.6953.6950%4.971-26%4.267-13%3.753-2%3.297+12%
Debt To Asset Ratio--0.1870.1870%0.165+14%0.180+4%0.212-12%0.251-26%
Debt To Equity Ratio--0.2300.2300%0.197+17%0.220+4%0.273-16%0.346-34%
Dividend Per Share--0.5350.5350%0.803-33%0.446+20%0.415+29%0.695-23%
Enterprise Value--1353228061.2501353228061.2500%692337179.960+95%1039994835.103+30%1360392415.202-1%1127553269.451+20%
Eps--1.4331.4330%1.048+37%1.285+12%1.152+24%0.748+92%
Ev To Sales Ratio--20.40820.4080%12.686+61%17.055+20%26.677-23%24.892-18%
Free Cash Flow Per Share--1.0971.0970%0.657+67%0.875+25%0.839+31%0.539+104%
Free Cash Flow To Equity Per Share--1.0971.0970%0.657+67%0.868+26%0.689+59%0.458+140%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.184----------
Intrinsic Value_10Y_min--8.239----------
Intrinsic Value_1Y_max--0.995----------
Intrinsic Value_1Y_min--0.844----------
Intrinsic Value_3Y_max--3.315----------
Intrinsic Value_3Y_min--2.536----------
Intrinsic Value_5Y_max--6.026----------
Intrinsic Value_5Y_min--4.213----------
Market Cap1743728395.800+21%1373925717.0501373925717.0500%707236746.560+94%1057432632.303+30%1376849333.5220%887990495.107+55%
Net Profit Margin--0.3760.3760%0.334+13%0.371+1%0.360+5%0.284+32%
Operating Margin----0%-0%0.173-100%0.281-100%0.269-100%
Operating Ratio--0.5830.5830%0.684-15%0.620-6%0.634-8%0.733-20%
Pb Ratio19.354+21%15.25015.2500%9.350+63%13.300+15%26.395-42%19.458-22%
Pe Ratio69.914+21%55.08755.0870%38.785+42%46.505+18%77.625-29%60.826-9%
Price Per Share100.200+21%78.95078.9500%40.640+94%60.763+30%79.1180%51.027+55%
Price To Free Cash Flow Ratio91.318+21%71.95271.9520%61.843+16%68.584+5%98.087-27%77.861-8%
Price To Total Gains Ratio73.364+21%57.80557.8050%38.670+49%47.618+21%78.064-26%62.192-7%
Quick Ratio--0.5420.5420%0.632-14%0.545-1%0.563-4%0.677-20%
Return On Assets--0.2250.2250%0.201+12%0.233-3%0.254-12%0.212+6%
Return On Equity--0.2770.2770%0.241+15%0.284-3%0.327-15%0.281-2%
Total Gains Per Share--1.3661.3660%1.051+30%1.256+9%1.138+20%1.270+8%
Usd Book Value--104564139.779104564139.7790%87786949.296+19%91708754.808+14%74348767.410+41%50164567.531+108%
Usd Book Value Change Per Share--0.9640.9640%0.288+235%0.940+3%0.840+15%0.668+44%
Usd Book Value Per Share--6.0096.0090%5.045+19%5.270+14%4.272+41%2.883+108%
Usd Dividend Per Share--0.6210.6210%0.932-33%0.518+20%0.481+29%0.807-23%
Usd Enterprise Value--1570556487.8871570556487.8870%803526531.062+95%1207018005.621+30%1578871437.083-1%1308638324.525+20%
Usd Eps--1.6631.6630%1.216+37%1.491+12%1.337+24%0.868+92%
Usd Free Cash Flow--22161811.59222161811.5920%13272644.580+67%17677758.981+25%16949343.070+31%10877150.318+104%
Usd Free Cash Flow Per Share--1.2731.2730%0.763+67%1.016+25%0.974+31%0.625+104%
Usd Free Cash Flow To Equity Per Share--1.2731.2730%0.763+67%1.007+26%0.799+59%0.531+140%
Usd Market Cap2023771176.165+21%1594578187.2081594578187.2080%820818968.058+94%1227256313.051+30%1597971336.4860%1030601768.621+55%
Usd Price Per Share116.292+21%91.62991.6290%47.167+94%70.522+30%91.8240%59.222+55%
Usd Profit--28946511.83328946511.8330%21163307.952+37%25951570.303+12%23267743.664+24%15112793.444+92%
Usd Revenue--76956523.49676956523.4960%63337430.764+22%69768073.727+10%63896810.206+20%45723616.045+68%
Usd Total Gains Per Share--1.5851.5850%1.220+30%1.458+9%1.321+20%1.474+8%
 EOD+4 -4MRQTTM+0 -0YOY+27 -103Y+27 -115Y+26 -1210Y+30 -8

3.3 Fundamental Score

Let's check the fundamental score of ChemoMetec A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1569.914
Price to Book Ratio (EOD)Between0-119.354
Net Profit Margin (MRQ)Greater than00.376
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.542
Current Ratio (MRQ)Greater than13.695
Debt to Asset Ratio (MRQ)Less than10.187
Debt to Equity Ratio (MRQ)Less than10.230
Return on Equity (MRQ)Greater than0.150.277
Return on Assets (MRQ)Greater than0.050.225
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of ChemoMetec A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.615
Ma 20Greater thanMa 5089.649
Ma 50Greater thanMa 10080.994
Ma 100Greater thanMa 20075.204
OpenGreater thanClose95.900
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerod, Denmark.

Fundamental data was last updated by Penke on 2025-10-12 13:56:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Chemometec earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Net Profit Margin of 37.6% means that €0.38 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChemoMetec A/S:

  • The MRQ is 37.6%. The company is making a huge profit. +2
  • The TTM is 37.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ37.6%TTM37.6%0.0%
TTM37.6%YOY33.4%+4.2%
TTM37.6%5Y36.0%+1.6%
5Y36.0%10Y28.4%+7.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ37.6%-4.5%+42.1%
TTM37.6%-5.8%+43.4%
YOY33.4%-11.0%+44.4%
3Y37.1%-12.3%+49.4%
5Y36.0%-11.1%+47.1%
10Y28.4%-9.6%+38.0%
4.3.1.2. Return on Assets

Shows how efficient Chemometec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • 22.5% Return on Assets means that Chemometec generated €0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChemoMetec A/S:

  • The MRQ is 22.5%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 22.5%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ22.5%TTM22.5%0.0%
TTM22.5%YOY20.1%+2.4%
TTM22.5%5Y25.4%-2.9%
5Y25.4%10Y21.2%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ22.5%-1.4%+23.9%
TTM22.5%-1.3%+23.8%
YOY20.1%-2.4%+22.5%
3Y23.3%-2.4%+25.7%
5Y25.4%-2.2%+27.6%
10Y21.2%-1.5%+22.7%
4.3.1.3. Return on Equity

Shows how efficient Chemometec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • 27.7% Return on Equity means Chemometec generated €0.28 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChemoMetec A/S:

  • The MRQ is 27.7%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 27.7%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ27.7%TTM27.7%0.0%
TTM27.7%YOY24.1%+3.6%
TTM27.7%5Y32.7%-5.0%
5Y32.7%10Y28.1%+4.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ27.7%-1.1%+28.8%
TTM27.7%-1.3%+29.0%
YOY24.1%-2.4%+26.5%
3Y28.4%-3.2%+31.6%
5Y32.7%-3.9%+36.6%
10Y28.1%-3.9%+32.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ChemoMetec A/S.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Chemometec is operating .

  • Measures how much profit Chemometec makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChemoMetec A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y28.1%-28.1%
5Y28.1%10Y26.9%+1.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--10.7%+10.7%
TTM--12.8%+12.8%
YOY--14.0%+14.0%
3Y17.3%-9.4%+26.7%
5Y28.1%-9.0%+37.1%
10Y26.9%-8.6%+35.5%
4.3.2.2. Operating Ratio

Measures how efficient Chemometec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.58 means that the operating costs are €0.58 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.583. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.583. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.583TTM0.5830.000
TTM0.583YOY0.684-0.101
TTM0.5835Y0.634-0.051
5Y0.63410Y0.733-0.098
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5831.297-0.714
TTM0.5831.316-0.733
YOY0.6841.221-0.537
3Y0.6201.285-0.665
5Y0.6341.287-0.653
10Y0.7331.269-0.536
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ChemoMetec A/S.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Chemometec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.70 means the company has €3.70 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of ChemoMetec A/S:

  • The MRQ is 3.695. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.695. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.695TTM3.6950.000
TTM3.695YOY4.971-1.276
TTM3.6955Y3.753-0.058
5Y3.75310Y3.297+0.456
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6952.395+1.300
TTM3.6952.593+1.102
YOY4.9712.691+2.280
3Y4.2672.836+1.431
5Y3.7533.574+0.179
10Y3.2973.433-0.136
4.4.3.2. Quick Ratio

Measures if Chemometec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Quick Ratio of 0.54 means the company can pay off €0.54 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.542. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.542. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.542TTM0.5420.000
TTM0.542YOY0.632-0.090
TTM0.5425Y0.563-0.022
5Y0.56310Y0.677-0.113
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5421.324-0.782
TTM0.5421.458-0.916
YOY0.6321.724-1.092
3Y0.5451.896-1.351
5Y0.5632.290-1.727
10Y0.6772.521-1.844
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ChemoMetec A/S.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Chemometec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chemometec to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that Chemometec assets are financed with 18.7% credit (debt) and the remaining percentage (100% - 18.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.187. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.187. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.187TTM0.1870.000
TTM0.187YOY0.165+0.022
TTM0.1875Y0.212-0.025
5Y0.21210Y0.251-0.039
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1870.414-0.227
TTM0.1870.426-0.239
YOY0.1650.393-0.228
3Y0.1800.397-0.217
5Y0.2120.407-0.195
10Y0.2510.455-0.204
4.5.4.2. Debt to Equity Ratio

Measures if Chemometec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Debt to Equity ratio of 23.0% means that company has €0.23 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.230. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.230. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.230TTM0.2300.000
TTM0.230YOY0.197+0.033
TTM0.2305Y0.273-0.043
5Y0.27310Y0.346-0.073
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2300.642-0.412
TTM0.2300.667-0.437
YOY0.1970.584-0.387
3Y0.2200.646-0.426
5Y0.2730.632-0.359
10Y0.3460.753-0.407
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Chemometec generates.

  • Above 15 is considered overpriced but always compare Chemometec to the Medical Devices industry mean.
  • A PE ratio of 55.09 means the investor is paying €55.09 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChemoMetec A/S:

  • The EOD is 69.914. Based on the earnings, the company is expensive. -2
  • The MRQ is 55.087. Based on the earnings, the company is expensive. -2
  • The TTM is 55.087. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD69.914MRQ55.087+14.827
MRQ55.087TTM55.0870.000
TTM55.087YOY38.785+16.302
TTM55.0875Y77.625-22.538
5Y77.62510Y60.826+16.799
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD69.914-0.829+70.743
MRQ55.087-0.999+56.086
TTM55.087-1.165+56.252
YOY38.785-2.555+41.340
3Y46.505-1.052+47.557
5Y77.625-1.079+78.704
10Y60.826-1.014+61.840
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChemoMetec A/S:

  • The EOD is 91.318. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 71.952. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 71.952. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD91.318MRQ71.952+19.366
MRQ71.952TTM71.9520.000
TTM71.952YOY61.843+10.109
TTM71.9525Y98.087-26.136
5Y98.08710Y77.861+20.226
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD91.318-1.562+92.880
MRQ71.952-1.808+73.760
TTM71.952-1.528+73.480
YOY61.843-3.264+65.107
3Y68.584-2.204+70.788
5Y98.087-3.976+102.063
10Y77.861-4.006+81.867
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Chemometec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 15.25 means the investor is paying €15.25 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of ChemoMetec A/S:

  • The EOD is 19.354. Based on the equity, the company is expensive. -2
  • The MRQ is 15.250. Based on the equity, the company is expensive. -2
  • The TTM is 15.250. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD19.354MRQ15.250+4.105
MRQ15.250TTM15.2500.000
TTM15.250YOY9.350+5.900
TTM15.2505Y26.395-11.145
5Y26.39510Y19.458+6.937
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD19.3542.318+17.036
MRQ15.2502.158+13.092
TTM15.2502.317+12.933
YOY9.3502.514+6.836
3Y13.3002.751+10.549
5Y26.3953.894+22.501
10Y19.4584.355+15.103
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets828,046
Total Liabilities154,691
Total Stockholder Equity673,355
 As reported
Total Liabilities 154,691
Total Stockholder Equity+ 673,355
Total Assets = 828,046

Assets

Total Assets828,046
Total Current Assets543,162
Long-term Assets284,884
Total Current Assets
Cash And Cash Equivalents 341,849
Net Receivables 79,618
Inventory 109,336
Total Current Assets  (as reported)543,162
Total Current Assets  (calculated)530,803
+/- 12,359
Long-term Assets
Property Plant Equipment 115,614
Goodwill 7,350
Intangible Assets 145,692
Long-term Assets  (as reported)284,884
Long-term Assets  (calculated)268,656
+/- 16,228

Liabilities & Shareholders' Equity

Total Current Liabilities146,992
Long-term Liabilities7,699
Total Stockholder Equity673,355
Total Current Liabilities
Short Long Term Debt 1,465
Accounts payable 16,079
Other Current Liabilities 1
Total Current Liabilities  (as reported)146,992
Total Current Liabilities  (calculated)17,545
+/- 129,447
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,939
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)7,699
Long-term Liabilities  (calculated)4,940
+/- 2,759
Total Stockholder Equity
Retained Earnings 542,880
Total Stockholder Equity (as reported)673,355
Total Stockholder Equity (calculated)542,880
+/- 130,475
Other
Capital Stock17,402
Common Stock Shares Outstanding 17,402
Net Invested Capital 674,820
Net Working Capital 396,170
Property Plant and Equipment Gross 205,967



6.2. Balance Sheets Structured

Currency in DKK. All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
> Total Assets 
97,620
113,995
238,215
263,116
344,909
501,273
657,976
676,673
828,046
828,046676,673657,976501,273344,909263,116238,215113,99597,620
   > Total Current Assets 
41,018
46,806
154,828
168,261
244,357
352,934
492,661
489,796
543,162
543,162489,796492,661352,934244,357168,261154,82846,80641,018
       Cash And Cash Equivalents 
12,395
9,780
98,195
96,941
150,109
209,025
316,571
296,146
341,849
341,849296,146316,571209,025150,10996,94198,1959,78012,395
       Net Receivables 
15,309
20,191
37,116
35,441
50,644
65,867
54,830
62,257
79,618
79,61862,25754,83065,86750,64435,44137,11620,19115,309
       Inventory 
13,314
16,835
19,517
25,112
30,113
66,790
112,635
119,495
109,336
109,336119,495112,63566,79030,11325,11219,51716,83513,314
   > Long-term Assets 
56,602
67,189
83,387
94,855
100,552
148,338
165,315
186,877
284,884
284,884186,877165,315148,338100,55294,85583,38767,18956,602
       Property Plant Equipment 
26,424
28,938
38,145
43,361
42,496
74,783
82,685
92,049
115,614
115,61492,04982,68574,78342,49643,36138,14528,93826,424
       Goodwill 
0
0
0
0
0
0
0
0
7,350
7,35000000000
       Intangible Assets 
30,048
38,205
45,131
51,383
57,884
67,398
79,663
94,547
145,692
145,69294,54779,66367,39857,88451,38345,13138,20530,048
       Other Assets 
130
46
111
111
172
6,158
2,967
0
0
002,9676,15817211111146130
> Total Liabilities 
33,243
40,985
64,874
60,365
79,932
144,068
124,934
111,357
154,691
154,691111,357124,934144,06879,93260,36564,87440,98533,243
   > Total Current Liabilities 
21,082
17,871
54,980
47,680
71,973
137,378
119,191
98,529
146,992
146,99298,529119,191137,37871,97347,68054,98017,87121,082
       Short Long Term Debt 
9,642
1,703
18,795
424
592
1,025
1,011
1,331
1,465
1,4651,3311,0111,02559242418,7951,7039,642
       Accounts payable 
4,888
7,264
9,707
8,427
8,710
17,023
17,550
11,085
16,079
16,07911,08517,55017,0238,7108,4279,7077,2644,888
       Other Current Liabilities 
295
323
7,177
20,633
40,571
88,245
89,920
0
1
1089,92088,24540,57120,6337,177323295
   > Long-term Liabilities 
12,161
23,114
9,894
12,685
7,959
6,690
5,743
12,828
7,699
7,69912,8285,7436,6907,95912,6859,89423,11412,161
       Long term Debt 
10,928
17,755
0
0
0
0
0
0
0
000000017,75510,928
       Capital Lease Obligations Min Short Term Debt
1,284
648
0
1,867
1,766
5,769
6,149
2,824
4,939
4,9392,8246,1495,7691,7661,86706481,284
       Other Liabilities 
216
4,711
9,894
11,495
7,047
1,830
2,100
0
0
002,1001,8307,04711,4959,8944,711216
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
1
100000000
> Total Stockholder Equity
64,377
73,010
173,341
202,751
264,977
357,205
533,042
565,316
673,355
673,355565,316533,042357,205264,977202,751173,34173,01064,377
   Common Stock
17,402
17,402
17,402
17,402
17,402
17,402
17,402
0
0
0017,40217,40217,40217,40217,40217,40217,402
   Retained Earnings 
46,582
55,226
155,553
185,335
247,571
339,777
515,622
478,292
542,880
542,880478,292515,622339,777247,571185,335155,55355,22646,582
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
393
382
386
14
4
26
18
0
0
001826414386382393



6.3. Balance Sheets

Currency in DKK. All numbers in thousands.




6.4. Cash Flows

Currency in DKK. All numbers in thousands.




6.5. Income Statements

Currency in DKK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in DKK. All numbers in thousands.

Gross Profit (+$)
totalRevenue495,572
Cost of Revenue-30,063
Gross Profit465,509465,509
 
Operating Income (+$)
Gross Profit465,509
Operating Expense-259,055
Operating Income236,517206,454
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense259,0550
 
Net Interest Income (+$)
Interest Income5,899
Interest Expense-558
Other Finance Cost-67
Net Interest Income5,274
 
Pretax Income (+$)
Operating Income236,517
Net Interest Income5,274
Other Non-Operating Income Expenses-
Income Before Tax (EBT)240,013236,517
EBIT - interestExpense = -558
186,405
186,963
Interest Expense558
Earnings Before Interest and Taxes (EBIT)-240,571
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax240,013
Tax Provision-53,608
Net Income From Continuing Ops186,405186,405
Net Income186,405
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--5,274
 

Technical Analysis of Chemometec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chemometec. The general trend of Chemometec is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chemometec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Chemometec Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChemoMetec A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 93.15 > 85.30 > 82.06.

Know someone who trades $CHY? Share this with them.👇

ChemoMetec A/S Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChemoMetec A/S. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChemoMetec A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChemoMetec A/S. The current macd is 3.79424082.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chemometec price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Chemometec. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Chemometec price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ChemoMetec A/S Daily Moving Average Convergence/Divergence (MACD) ChartChemoMetec A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChemoMetec A/S. The current adx is 32.68.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Chemometec shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
ChemoMetec A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChemoMetec A/S. The current sar is 86.05.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ChemoMetec A/S Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChemoMetec A/S. The current rsi is 72.61. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
ChemoMetec A/S Daily Relative Strength Index (RSI) ChartChemoMetec A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChemoMetec A/S. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chemometec price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
ChemoMetec A/S Daily Stochastic Oscillator ChartChemoMetec A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChemoMetec A/S. The current cci is 211.51.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ChemoMetec A/S Daily Commodity Channel Index (CCI) ChartChemoMetec A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChemoMetec A/S. The current cmo is 53.78.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ChemoMetec A/S Daily Chande Momentum Oscillator (CMO) ChartChemoMetec A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChemoMetec A/S. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
ChemoMetec A/S Daily Williams %R ChartChemoMetec A/S Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChemoMetec A/S.

ChemoMetec A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChemoMetec A/S. The current atr is 2.14774813.

ChemoMetec A/S Daily Average True Range (ATR) ChartChemoMetec A/S Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChemoMetec A/S. The current obv is -565.

ChemoMetec A/S Daily On-Balance Volume (OBV) ChartChemoMetec A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChemoMetec A/S. The current mfi is 59.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ChemoMetec A/S Daily Money Flow Index (MFI) ChartChemoMetec A/S Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChemoMetec A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-02 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-18 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-22 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-01 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-13 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-15 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-18 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-05 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-15 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-26 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-30 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-02 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-07 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-09 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-10-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-16 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-17 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-22 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-28 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

ChemoMetec A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChemoMetec A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.615
Ma 20Greater thanMa 5089.649
Ma 50Greater thanMa 10080.994
Ma 100Greater thanMa 20075.204
OpenGreater thanClose95.900
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Chemometec with someone you think should read this too:
  • Are you bullish or bearish on Chemometec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chemometec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChemoMetec A/S

I send you an email if I find something interesting about ChemoMetec A/S.


Comments

How you think about this?

Leave a comment

Stay informed about ChemoMetec A/S.

Receive notifications about ChemoMetec A/S in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.